Hearing loss in patients with vestibular schwannoma, both before and after treatment, is known to negatively impact quality of life.

Hearing loss in patients with vestibular schwannoma, both before and after treatment, is known to negatively impact quality of life.
Despite the increased morbidity and risks associated with revision surgery, select patients benefit from re-operation in the setting of recurrent well-differentiated thyroid cancer.
The literature supports the use of thyroglobylin washout as an adjunct to fine-needle aspiration cytology (FNAC) as it improves diagnostic accuracy.
Observation following a positive sentinel lymph node biopsy (SLNB) for head and neck cutaneous melanoma (HNCM) is likely a reasonable approach to offer patients, as survival is unchanged in prospective clinical trials.
Is there a role for bedside biopsy in the evaluation of acute invasive fungal rhinosinusitis?
Identification of sentinel lymph nodes (SLNs) in head and neck melanoma can be particularly challenging, due in part to the unpredictable and diffuse lymphatic drainage of the head and neck.
We review the current evidence to determine if cochlear implantation is an effective intervention for auditory rehabilitation after vestibular schwannoma treatment.
There is no conclusive evidence that extraction is required when a healthy tooth is present within the fracture line.
Currently, there are no guidelines for the management of retained tubes in asymptomatic patients. Should they be removed?
Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits clot breakdown and is well described in the literature toreduce intraoperative blood loss in craniofacial, cardiac, trauma, dermatologic, and orthopedic surgeries.